IKDCs can kill tumors, function as APCs by capturing apoptotic tumor cells [6–8], and target and eliminate tumors while cross-presenting tumor antigens to prime CD8 T cells with tumor specificity [9]. The gene discussed is CD8A; the disease is neoplasm.